5-Fluoro-2-methoxypyridine | CAS:51173-04-7

We serve 5-Fluoro-2-methoxypyridine CAS:51173-04-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Fluoro-2-methoxypyridine

Chemical Name:    5-Fluoro-2-methoxypyridine
CAS.NO: 51173-04-7
Synonyms:5-Fluoro-2-Methoxypyridine;
2-Methoxy-5-Fluoropyridine;
Molecular Formula: C6H6FNO
Molecular Weight: 127.11600
 
Physical and Chemical Properties:
Density: 1.146g/cm3
Melting point: /
Boiling point: 144.8ºC at 760 mmHg
Flash point:  41.4ºC
Index of Refraction: 1.471
 
Specification:
Appearance: White Crystalline Powder
Purity:≥99.0%
 
Packing:25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:    used to Organic Intermediate



Contact us for information like 5-Fluoro-2-methoxypyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methoxy-5-Fluoropyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methoxy-5-Fluoropyridine Use and application,2-Methoxy-5-Fluoropyridine technical grade,usp/ep/jp grade.


Related News: Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it.2-Bromobenzaldehyde manufacturer Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it.1,1-Cyclobutanedimethanol supplier Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).1-fluoro-3-chloropropane vendor Since first being reported in the city of Wuhan, where it is believed to have originated at a seafood market, the virus has not provoked unusual symptoms in people who have been diagnosed.The Ministry of Agriculture said late Saturday that a fresh outbreak of a lethal form of influenza had been found in poultry in the southern province of Hunan, and that officials had ordered the slaughter of 17,828 chickens.